SPDR S&P Biotech ETF (XBI) options active amid FDA leadership headlines
Tweet
Share
E-mailSPDR S&P Biotech ETF (NYSE: XBI) 30-day option implied volatility is at 40; compared to its 52-week range of 24 to 62 amid FDA leadership headlines.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stocks expected to have increasing option volume: LOW TGT ADI RDDT TJX EL DE WMT TOL PONY WYFI LZB
- EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
- Jefferies Upgrades Dollar Tree (DLTR) to Hold
Create E-mail Alert Related Categories
OptionsRelated Entities
Standard & Poor's, Options, Maynard Um, Mark Zuckerberg, FDA, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
